Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

NEW ORLEANS, LA—A novel transcatheter intracardiac shunt device appears to provide sustained clinical benefit at 1 year in heart failure patients with preserved or only mildly reduced ejection ...

Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

For babies born with some types of congenital heart disease that require palliative procedures within the first few months of life, scientists are debating which procedure is the best. In a new study ...

Transcatheter implants designed to alleviate high left atrial (LA) pressures — which, as a possible way to treat heart failure (HF) once seemed like a long shot — are emerging as new stars of heart ...

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure ...

V-Wave has raised $98 million to complete the clinical testing of its implant for severe heart failure and pulmonary arterial hypertension, as well as set up the device for FDA review. The company’s ...

Jimmy McMillan, 69, of West Columbia felt his health growing worse as his heart failure progressed. “I would have trouble just walking down to the mailbox and back without having to stop and catch my ...

NEW ORLEANS, LA — For patients with heart failure with preserved ejection fraction, implantation of an interatrial shunt device appeared to be safe and was associated with clinical and hemodynamic ...

Aseptic intracardiac shunts are not frequently seen after TAVR, estimated to occur in only about 0.5% of cases, according to a systematic review. But when conservative management is used, mortality is ...